Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency
Apply
Lorigerlimab
Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step